1. Executive Summary

Total Page:16

File Type:pdf, Size:1020Kb

1. Executive Summary Executive Summary - Sample Pages 1. Executive Summary 2011 was another turbulent year for private that closed in 2011, up from $277bn by funds Fig. 1.1: All Private Equity Fundraising by Quarter, Q1 2004 - Q4 2011 equity fundraising. A considerable 62% of that closed in 2010. Though the increase is investors Preqin spoke to back in December modest, 2011 is the first year since 2008 that 250 2010 planned to make new commitments to there has not been a fall in the aggregate 212.5 210.4 private equity funds over the course of 2011, capital raised by private equity funds. 204.2 and an encouraging 68% of investors that 200 174.7 were looking to invest planned to commit Investor Appetite and Impact of Market 168.7 more capital in 2011 than they did in 2010. Volatility 152.5 150 Fundraising did indeed pick up in the first half 140.8 131.8 128.4 123.8 127.9 of the year, and we saw a quarter-on-quarter Although financial markets remain 119.3 101.6 110.0 increase in capital raised by closed funds, unpredictable, a significant 73% of investors 100 95.4 85.3 87.3 from $55.9bn in Q4 2010 to $87.3bn in Q2 we spoke to in December are planning 79.1 74.578.8 79.9 69.6 68.2 57.0 61.5 62.4 2011 (see Fig. 1.1). to make new private equity commitments 57.5 55.9 52.6 52.2 53.1 over the course of 2012. Furthermore, of 50 48.7 However, the second half of the year saw those planning to invest in 2012, 27% plan Commitments ($bn) Aggregate disappointing levels of fundraising as the to commit more capital while 49% intend to crisis within the eurozone impacted on wider commit at the same rate as they did in 2011 0 financial markets, and Q3 saw the amount (see Fig. 1.2). Another 12% of LPs making of capital raised dip to its lowest point since new commitments in 2012 are returning to Q12004 Q22004 Q32004 Q42004 Q12005 Q22005 Q32005 Q42005 Q12006 Q22006 Q32006 Q42006 Q12007 Q22007 Q32007 Q42007 Q12008 Q22008 Q32008 Q42008 Q12009 Q22009 Q32009 Q42009 Q12010 Q22010 Q32010 Q42010 Q12011 Q22011 Q32011 Q42011 Q4 2004, with 137 funds closing on $53.1bn, the asset class having held off from making before there was a slight uptick again in Q4 new commitments in 2011, suggesting 2011. that several investors are becoming more Like many investors we spoke to, an Australian Nineteen percent of investors interviewed told confident about the opportunities on offersuperannuation scheme feels that: “Public us they view private equity more negatively Despite the increased volatility within within private equity. markets are more volatile and risky in times as a result of volatility in wider financial financial markets, many investors remain like this, so private equity becomes more markets; some voiced concerns that public optimistic about the opportunities on offer A significant 61% of investors told us that attractive.” A Canadian endowment told us: market losses are increasing the risk of the within the private equity asset class, and 66% recent volatility in wider markets, and in “[There is] more value in private equity after denominator effect in their private equity of investors we spoke to in December 2011 particular the sovereign debt crisis in Europe, [the] fall in public markets.” Many investors we portfolios, whereas others had concerns told us they had made new commitments to has not impacted upon their opinion of the spoke to also feel that the current climate in about maturing funds within their portfolios the asset class over the course of the year. asset class; in fact one fifth of investors feelEurope is opening up opportunities in certain being able to realize their investments. Private equity fundraising remains muted in more positive towards private equity as a markets, as a Singaporean investment comparison to the years prior to the financial result of the problems in the eurozone. Full company acknowledged: “The volatility has Key Geographies for 2012 crisis, but some encouragement can be analysis of the results of our December 2011 not negatively influenced our attitude towards taken from the fact that the aggregate capital investor interviews are available within the private equity since we feel there could be As the more developed private equity markets received by funds that closed in 2011 saw a body of the 2012 Preqin Limited Partner opportunities in the current situation in terms in Europe and North America face economic slight increase on the capital raised by funds Universe. of distressed assets in need of funding.” instability and stricter regulations, investors closed in 2010, with $278.3bn raised by funds are increasingly looking to opportunities © 2012 Preqin Ltd 1 Executive Summary - Sample Pages in other regions. A significant 60% of Furthermore, 99% of investors that invest in Fig. 1.2: Amount of Capital Investors Plan to Commit to Private Equity Funds in 2012 Compared investors we spoke to in December feel emerging markets expect to maintain (66%) to 2011 that Asia is presenting attractive investment or increase (33%) their allocation to such Significantly More opportunities in the current market. Forty-two regions over the next 12 months. Capital in 2012 than in percent of LPs named North America as an 12% 6% 2011 attractive region to invest in at present (see The 2012 Preqin Limited Partner Universe 2% Slightly More Capital in 21% Fig. 1.3). Despite recent uncertainty in the 2012 than in 2011 contains profiles for over 2,800 institutional 10% eurozone, 37% of investors feel that regions investors in private equity, and includes within Europe are presenting attractive information on their geographic and strategic Same Amount of preferences, as well as a sample of the Capital in 2012 as in investment opportunities. Specific regions 2011 within Europe that were named by investors previous private equity fund investments Slightly Less Capital in as offering appealing opportunities at present they have made. 2012 than in 2011 include the Nordic region as well as countries in Central and Eastern Europe. GP Relationships 49% Significantly Less Capital in 2012 than in 2011 Importantly, 70% of investors told us that Although the majority of LPs have capital they are not avoiding any regions where they available and are ready to make new fund Did Not Invest in 2011 would have previously considered gaining commitments, fund managers on the road but Investing in 2012 exposure in light of the current financialare likely to face tough challenges in the climate, including one Singapore-based coming months; with a record number of investment company which commented: funds in the market investors remain highly “There is always an opportunity in a crisis. selective about the managers they choose to Fig. 1.3: Regions Investors View as Presenting Attractive Opportunities and Regions Investors Are Even in situations like the one currently in work with. Avoiding in the Current Financial Climate Europe, for example, distressed assets could always be a draw so we are keeping our Managers should be aware that while a 80% options open and not ruling out investing in considerable 84% of investors are likely 70% 70% any region.” Eighteen percent of LPs told us to add some new GPs to their portfolios, Regions Investors View they will avoid certain regions within Europe several are also likely to terminate some 60% as Presenting Attractive as a result of the current climate; within existing relationships if managers do not 60% Opportunities in the Europe investors named Southern Europe, meet their high expectations or increasingly Current Financial 50% Climate Greece, Italy and Spain as areas they would stringent investment criteria. Therefore 42% avoid in the current financial climate. Twelve managers planning to launch follow-on funds 40% 37% percent of investors are avoiding funds in the coming months should closely monitor Regions Investors Are targeting Rest of World (regions outside of their existing LP base in order to assess 30% 26% Avoiding Due to the North America, Europe and Asia). which LPs they expect will re-up with them, Current Financial and thus ascertain how much capital they 20% 18% Climate, Where They Emerging markets continue to attract strong will need to attract from new investors when of Respondents Proportion 12% Would Have Considered 8% Investing Before interest from investors. Seventy-six percent of beginning the fundraising process. More than 10% 6% investors will consider investing in emerging a quarter (26%) of funds that closed in 2010 2% markets, an increase of six percentage points and 2011 have an investor base consisting 0% Europe North Asia Rest of World None from December 2010, when 70% of investors of a majority of investors that they had not America were open to investing in emerging markets. previously worked with. © 2012 Preqin Ltd 2 Executive Summary - Sample Pages Investors continue to be reluctant to commit and then receive a follow up call from the Fig. 1.4: Investors’ Preferred Method of Contact from Fund Managers to funds raised by new teams: 55% of GP. Just 5% of investors prefer to receive investors told us they will not consider an introductory call from a manager without investing in a first-time fund over theany next prior contact, while 9% of investors Receive Email with Fund Documentation and No Follow-up Call 31% 12 months. Just 18% of LPs told us they named other ways in which they would like from the Fund Manager would readily invest in a first-time fund overto be approached, including receiving fund the next 12 months, and an additional 17% documentation in hard copy through the Contact via Investment Consultant would consider committing to a first-time fund post, contacting a specific person within 27% should they see an appealing opportunity.
Recommended publications
  • Entrepreneurship in Spain
    All you need to know about entrepreneurship in Spain June 2021 edition A way to make Europe EUROPEAN REGIONAL DEVELOPMENT1 FUND CONTENT Part I – STARTING POINT • Creating a startup Part II – RESOURCES FOR STARTUPS • Resources for startups • Incubators • Accelerators • Specific services suppliers Part III – FINANCING FOR STARTUPS • How to obtain financing • Private sector • Public sector • European calls • National calls Part IV – EVENTS FOR STARTUPS • Events Part V – AUTONOMOUS REGIONS • Programs and subsidies for startups This guide is intended as a collection of resources for startups in their different stages of seeking public and/or private funding 2 Part I Starting point CREATING A STARTUP IN SPAIN The steps to establish a startup are the same as for any other company. The very first one is to determine the most appropriate legal form, a decision that will be influenced by the startup´s later needs regarding participation deals and receipt of third-party investment. The most used legal forms are: Spain • Limited Liability Company (Sociedad Limitada, S.L.) in • Corporation (Sociedad Anónima, S.A.). startup Both forms can also be set up as a sole-shareholder entity (Sociedad Anónima Unipersonal, S.A.U. and Sociedad Limitada Unipersonal, S.L.U. respectively) a at the time of incorporation or be converted into a sole-shareholder entity afterwards. While there are alternatives to these legal forms, they aren´t advisable for startups that will be seeking to add partners to the project and/or third-party investors. For information purposes, these include: Freelancer (Autónomo), Private partnership (Sociedad Civil) or Jointly-Owned Entity (Comunidad de creating Bienes), or a Cooperative (Cooperativa).
    [Show full text]
  • Article Communicate
    article communicate French Chapter of the Venture Capital Handbook for 2011 PLC www.morganlewis.com Venture Capital: France Resource type: Articles: know-how Status: Law stated as at 01-Nov-2010 Jurisdiction: France A Q&A guide to venture capital law in France. The Q&A gives a high level overview of the venture capital market; tax incentives; fund structures; fund formation and regulation; investor protection; founder and employee incentivisation and exits. For a full list of recommended venture capital law firms and lawyers in France, please visit PLC Which lawyer? This Q&A is part of the PLC multi-jurisdictional guide to venture capital. For a full list of jurisdictional Q&As visit www.practicallaw.com/vchandbook. Ann Baker, Anne Tolila, Karen Noël, Olivier Edwards and Olivier Couraud, Morgan Lewis & Bockius Contents Market Tax incentives Fund structure Fund formation and regulation Investor protection Founder and employee incentivisation Exits Contributor details Anne Tolila Karen Noël Ann G Baker Olivier Edwards Market 1. Please describe briefly the venture capital market in your jurisdiction, in particular: How it is distinguished from private equity. The sources from which early stage companies obtain funding. The types of companies that attract venture capital investment. Market trends (for example, levels of investment, the type of companies invested in and where those companies are located). Venture capital and private equity Venture capital distinguishes itself by the: Early stage of development of the companies which are funded. The absence of leverage and consequently of debt in the investment, which is generally made in equity. The following figures and more can be found on www.chaussonfinance.com.
    [Show full text]
  • Healthcap IV Established with Committed Capital of MSEK 3 000
    Odlander Fredrikson Group 2002-09-17 PRESS RELEASE HealthCap IV established with committed capital of MSEK 3 000 HealthCap IV was established in the summer of 2002 and now announces its final closing with a committed capital of SEK 3 000 000 000. HealthCap IV is a multi-stage venture capital fund investing in the medical sector. HealthCap invests internationally, with a focus on the Nordic region and Western Europe. The fund invests in commercialisation of medical science and innovations, in newly started companies as well as in more established enterprises. The three previous HealthCap funds will continue to make follow-on investments in existing portfolio companies. More than fifty initial investments have been made by these three funds, of which some 20 in start-up companies. Currently twelve of these companies have publicly quoted shares. HealthCap is seeking active partnership with portfolio companies and founders, providing assistance with inter alia company formation, formulation of strategies, management and financing. Investors in HealthCap IV include the 4th Swedish National Pension Fund, AGF Private Equity, AIG Global Investments, Allianz Private Equity, ATP Private Equity, Barclays Bank UK Retirement Fund, CDP Sofinov, Grove Street Advisors for CalPERS, HarbourVest Partners, MN Services, Swiss Re, Tapiola, TIFF, The Kresge Foundation, Toronto University, Vanderbilt University and Washington University. The Odlander Fredrikson Group is the exclusive investment advisor to the fund. MVision Private Equity Advisers Limited acted as global financial advisors to the Odlander Fredrikson Group, with CSFB and Handelsbanken as regional placing agents, in connection with the placing of the fund. For more information please contact Odlander Fredrikson Group Odlander, Fredrikson & Co AB Odlander Fredrikson SA Björn Odlander Peder Fredrikson tel.
    [Show full text]
  • European Telemedicine
    WWW.DRAKESTAR.COM APRIL 2021 6 Sector Report EUROPEAN TELEMEDICINE Christophe Morvan, Managing Partner Lawrence Giesen, Partner [email protected] [email protected] +33 170 087 610 +33 170 087 613 Grégoire Bizouerne, Analyst Antoine Pigneux, Analyst [email protected] [email protected] +33 170 087 615 +33 170 087 621 A MESSAGE FROM DRAKE STAR We are pleased to publish the inaugural 2021 Drake Star Telemedicine Sector Report presenting the European telemedicine market during an unprecedented year for the industry due to the ongoing Covid-19 outbreak. Our report will explore the uses of telemedicine, market trends, the impact of the Covid-19 crisis, interviews with leaders in the sector as well as an overview of the European landscape and its main players. We will include an extensive list of the recent private placement and M&A activity as well as an analysis of public markets valuations, including the launch of the Drake Star Telemedicine Index. We also provide 72 short profiles of European telemedicine companies, from startups to established firms, offering a diverse picture of the European market. The global telemedicine market recorded historic growth in 2020, reaching $52bn and is projected to triple by 2025 to over $150bn. Based on our estimations, the European market represents 20% of the global telemedicine market, but growing at a slower rate due to structural issues. Telemedicine adoption has been accompanied by a surge in fundraising, enabling platforms to scale quickly. We provide a mapping of the largest and most active financial and industrial investors in the space.
    [Show full text]
  • Connecting Private Equity and Venture Capital Investment Vehicles to Global Capital Sources the European Private Equity & Venture Capital Web Meeting
    Connecting Private Equity and Venture Capital Investment Vehicles to Global Capital Sources The European Private Equity & Venture Capital Web Meeting ZOOM & SLACK July 21st, 22nd & 23rd 2020 Central European Time LIVE ONLY, RECORDING IS PROHIBITED BUSINESS CASUAL ATTIRE The European Private Equity & Venture Capital Web Meeting ZOOM & SLACK– July 21st, 22nd & 23rd 2020 Dear Colleague, It is with great pleasure that I invite you to The European Private Equity & Venture Capital Web Meeting. The aim of this Web Meeting is to connect private equity & venture capital funds, family offices, institutional investors, and other industry professionals across Europe and the world. Our online meeting brings together over 400 c-level executives that will join us to virtually network and discuss investment opportunities, allocations, and the current performance of all private equity & venture capital related asset classes. Panel discussions to be covered include topic on institutional investor, family office, private equity, and venture capital perspectives. This is a live event and closed to the media. Video and audio recording of this event is strictly prohibited. We look forward to hosting you digitally! Best, Roy Carmo Salsinha President, CEO Carmo Companies By the Numbers… In Attendance… $5+ Trillion AUM in attendance • European focused Private • Multi Family Offices Equity Funds and Venture • Government officials 400+ Total participants Capital Funds • Economists 200+ Institutional & Private Wealth Investors • Hedge Funds • • Public Pension Funds Banks and Investment 200+ Private Equity & Venture Capital Funds Banks Managers • Corporate Pensions Funds • Lawyers • Pension Consultants 6 Industry Exclusive Panel Sessions • Auditors • Endowments 6 Hours of private virtual networking/speed dating Executives Level • Commercial Service - C • 3 Day Zoom Web Conference Foundations Providers • Fund of Funds 3 Day Slack networking tool access • Sovereign Wealth Funds • Single Family Offices WEB MEETING APPS • Our Video Conference will be Powered by ZOOM.
    [Show full text]
  • 3Rd FCF Life Science Venture Capital Report
    FCF Life Science Research 3rd Life Science Venture Capital Report – Financing Trends in Europe and the US Fungi Penicillium Part of FCF Life Science Research Series Executive Summary FCF Overview Funding Development in 2018 Life Sciences: A closer Look C r o s s - border Investment Activity Investor Analysis Life Science Exits 2 Executive Summary The FCF Life Science Venture Capital FCF Life Science Venture Capital Report Recipients Report is a is a comprehensive, standardized analysis for biotechnology, The FCF Life Science Venture Capital Report targets the following standardized report pharmaceutical and medical technology companies, examining recipients: focusing on venture recent venture capital deal trends in the European life science ▪ Corporates / Executives ▪ Venture capital investors capital deal industry ▪ Institutional investors ▪ Family Offices / High- characteristics in the ▪ Private equity investors net-worth individuals biotechnology, ▪ Advisors Selection of Companies pharmaceutical and medical technology The selection of companies is based on the following criteria: Availability segments, and can be used as a quick ▪ Companies operating in the biotechnology, pharmaceutical, The FCF Life Science Venture Capital Report is available on FCF’s reference for medical technology, services or other life science related sectors website at “https://www.fcf.de/de/research/life-science-research“ investors, corporates ▪ Sole focus on transactions involving European life science and professionals companies Data ▪ The therapeutics sector is further divided into the following All input data is provided by Pitchbook, S&P Capital IQ or More advanced, indications: Oncology, Central Nervous System, Infectious GlobalData and is not independently verified by FCF. Ratio and detailed and / or Diseases, Immunology, Ophthalmology, Rare Diseases, multiple calculations are driven based on the input data available.
    [Show full text]
  • Life Sciences Fundraising
    Fig. 1: Preqin Research Report - Sept 2009 Aggregate Capital Raised by Life Science Funds Private Equity Life Science Funds (1) 2007-2009 YTD 30 24.2 Life science, also known as Fundraising by Region 25 bioscience, comprises of several 20 branches of science, including Examining pure life science private 15 biology, medicine and ecology. This equity fundraising by regional focus $bn comprehensive scientific division is exposes the dominance of US 10.7 10 emerging as a burgeoning private focused funds in this sector. US 6.4 equity sector with a variety of funds focused life science private equity 5 4.0 2.6 hitting the market looking to invest funds have attracted far more 0.8 in firms that are developing ideas in aggregate capital than their global 0 biotechnology, pharmaceuticals and counterparts for each of the past 2007 2008 2009 YTD biomedical technologies. three years, securing more than $4 Non-Pure Life Science Pure Life Science billion in 2007, $2.4 billion in 2008 This research report contains key and nearly $2.5 billion in 2009. facts and statistics to help you European focused pure life science “ understand more about this growing funds have also had an impact on investment sector. global fundraising, drawing around $1.6 billion in aggregate capital ...The pure life science private equity Aggregate Capital Raised in 2007 and 2008. Fundraising in 2009 year-to-date has proved fundraising market is almost wholly Fig. 1 shows the aggregate capital more of a challenge, with only $70 comprised of venture vehicles... raised by all private equity funds million having been committed to involved with life sciences from life science funds closed so far this “ 2007 to 2009 year-to-date.
    [Show full text]
  • Biotechnology Startups Research Report
    GLOBAL BUSINESS CONFIDENCE REPORT 4th Qtr. 2019 B IOTECH NOLOGY STARTUPS RESEARCH REPORT 4th Quarter 2019 www.tradecouncil.org www.qibcertification.org International Trade Council www.tradecouncil.org www.goglobalawards.org Page 1 MARKET OVERVIEW REPORT FOR ENTERPRISE ESTONIA Table of Contents Overview ........................................................................................................................................................................... 3 Industry Definition .......................................................................................................................................................................................... 3 Sectoral Definitions ........................................................................................................................................................................................ 3 Main Activities .................................................................................................................................................................................................. 4 Associated Industries ..................................................................................................................................................................................... 4 Industry at a Glance ......................................................................................................................................................... 5 Industry Overview ..........................................................................................................................................................................................
    [Show full text]
  • Fourth Swedish National Pension Fund – Background
    ANNUAL REPORT 2002 1 Fourth Swedish National Pension Fund – Background History The Fourth Swedish National Pension Fund was founded in 1974. Investment goods The Fund is an independent state-owned body charged with managing assets to provide maximum benefit to the income-based retirement pension system. The Fund’s overall investment risk should be low. At the chosen risk level, Fund assets should be invested so as to secure a high long-term return. Board of Directors The Fund’s Board of Directors consists of nine full members, all appointed by the government. Investment rules The Fund’s investment rules in their current form entered force on 1 January 2001 and are as follows: ■ Investments are permitted in all forms of capital market instruments that are listed and liquid. ■ At least 30% of the Fund’s assets must be invested in fixed income securities with low credit and liquidity risk. ■ In 2001, the Fund was permitted to expose 15% of its assets to currency risk. Thereafter the Fund could increase exposure by 5% per annum up to a specified long-term maximum of 40%. ■ No more than 10% of the Fund’s assets may be exposed to a single issuer or group of connected issuers. ■ Equities in listed Swedish companies may not exceed 2% of stock market capitalisation. ■ The Fund may own shares corresponding to no more than 10% of the voting capital in any single listed company. ■ A maximum 5% of the Fund’s assets may be invested in unlisted securities. Such investments must be made indirectly via venture capital firms or similar entities.
    [Show full text]
  • The 29Th Medtech Investing Europe Conference 26 & 27 November 2019 • Bankside Hotel London, UK
    The 29th MedTech Investing Europe Conference 26 & 27 November 2019 • Bankside Hotel London, UK Delegate Guide & Programme Speaker Biographies MedTech Presenting Company Information Organised by: In Partnership with: Sponsored by: www.medtechinvesting.com Welcome 26 November 2019 Dear Participant, It gives me great pleasure to welcome you to the 29th MedTech Investing Europe Conference here in London. As always we have a packed conference programme, addressing some of the major challenges and opportunities in the sector today, as well as improved and extended networking opportunities, One- To-One meetings and the all-important Presenting Company streams bringing the latest technologies and investment opportunities. This year we are once again giving audience members the opportunity to vote for the “Best In Show Presenting Company” – with every delegate able to cast 1 vote via the event app and One-To-One networking system, the winner will be announced at the end of the conference. I would like to thank all those who have contributed to the organisation of the conference including our sponsors BioAlps, Canton of Vaud; our partners École Polytechnique Fédérale de Lausanne (EPFL) and of course all of our supporters. We are extremely grateful for the time and preparation our expert panel of speakers have put into being here to share with you their knowledge and expertise. Final thanks must go to the Presenting Companies, who will bring to you genuinely ground-breaking technologies that truly have the potential to be tomorrow’s game-changers. We constantly strive to develop events that reflect the needs of the healthcare sector; events that give essential and timely insight into today’s opportunities and challenges and provide the very best networking opportunities for both investors and technology providers alike.
    [Show full text]
  • Private Equity Market Activity
    P e n s i o n C o n s u l t i n g A l l i a n c e, I n c. Los Angeles • Portland • New York Los Angeles Department of Water and Power Employees’ Retirement Plan Private Equity Program Performance Report June 30, 2007 Prepared by: Pension Consulting Alliance, Inc. 0 P e n s i o n C o n s u l t i n g A l l i a n c e, I n c. Los Angeles • Portland • New York Table of Contents Page Program Overview 2 Private Equity Market Overview 3 Evolution and Current Status of the Private Equity Program 6 Investment Performance 7 Portfolio Structure 9 Summary 11 Appendix Tab A Tracking Schedule A-1 Landmark Equity Partners XIII, LP A-2 Lexington Capital Partners VI, LP A-3 Tab B Return Calculation Discussion B-1 1 P e n s i o n C o n s u l t i n g A l l i a n c e, I n c. Los Angeles • Portland • New York Program Overview The Los Angeles Department of Water and Power Employees’ Retirement Plan (“WPERP” or the “Plan”) Private Equity Program consists entirely of secondary market fund-of-funds to date. The Program is very young as the initial commitments to private equity were made in 2006. As private equity partnerships are long-term investments that are invested over several years, the Program is expected to continue to grow and evolve over time. Funding Projections The Program’s current long-term target allocation is 4% of the Plan’s total portfolio representing approximately $324 million in current market value.
    [Show full text]
  • International Corporate Finance M&A • Private Equity • Banking & Finance • Tax • Antitrust
    2016 EDITION INTERNATIONAL CORPORATE FINANCE M&A • PRIVATE EQUITY • BANKING & FINANCE • TAX • ANTITRUST Marco De Benedetti The Carlyle Group P. 54 Tania Daguere-Lindbäck Blackstone P. 38 Augusto Lima Anheuser-Busch InBev P. 45 Louis Schweitzer Renault P. 41 Luciane Ribeiro Santander Brasil Asset Management P. 37 Benedict Oramah Afreximbank P. 49 Mathilde Bluteau Microsoft France P. 35 Gaurav Malik Philips Lighting P. 42 Giselle Luna de Mello Wells Fargo GFI RANKINGS P. 51 AMERICAS P.67 EXTERNAL CONTRIBUTORS EXECUTIVE SUMMARY EUROPE P.149 EXPERT VIEWS P.326 THE GLOBAL MARKET: ASIA P.301 Jeff Immelt MONEY TALKS P.12 TOP ADVISORS DIRECTORY Argentina, Brazil, Canada, Chile, Colombia, GE PRIVATE EQUITY FIRMS P.334 Mexico, Peru, Uruguay, USA, Austria, Belgium, 50 LEADERS P. 42 France, Germany, Italy, Luxembourg, Netherlands, INVESTMENT BANKS THE 50 PEOPLE OF THE YEAR Poland, Portugal, Russia, Spain, Switzerland, UK, & FINANCIAL ADVISORS P.337 IN CORPORATE FINANCE P.34 China, India, Japan EXECUTIVE SEARCH & ADVISORY P.341 LAW FIRMS P.342 Customized legal and fi nancial translation services HIGHLY SPECIALIZED LEGAL AND FINANCIAL TRANSLATION SERVICES ■ A skilled, experienced and dynamic team of in-house fi nancial and legal translators ■ Project managers capable of handling all types of projects ■ A network of highly-skilled freelance translators ■ Ability to rapidly meet the constraints of our specialist sectors ■ An in-depth awareness of clients’ needs Legal translation Financial translation ■ Arbitration and litigation ■ Invest ment funds ■ International Trade ■ Banking ■ Corporate fi nance ■ Real Estate ■ Asset Management ■ Mining, Petroleum ■ Private Equity ■ Intellectual Property ■ Information Technology ■ International organisations We specialise in Investment Funds Over the past 10 years, Tradewords has built up a network of leading European fund specia- lists.
    [Show full text]